Inflammatory Markers Are Elevated in Eisenmenger Syndrome
Purpose
Inflammation is considered to be one of the important factors in the progression Eisenmenger syndrome (ES). Markers of systemic inflammation are not yet studied in Eisenmenger syndrome.
Methods
Twenty-two consecutive symptomatic patients of ES with a mean age of 24 ± 10.6 years, were enrolled in the study. Six (27%) patients had atrial septal defect, 8 patients (36%) had ventricular septal defect and 8 patients (36%) had patent ductus arteriosus. Thirteen (59%) patients were in WHO functional class II and nine (41%) patients were in WHO class III. Inflammatory markers including hs-CRP (high sensitivity C-reactive protein), interleukin-2, interleukin-6 and interferon γ were assayed with commercially available kits using ELISA and the values were compared with 6 healthy controls.
Results
There is significant elevation in hs-CRP and interferon γ levels as compared to controls. The results are summarized in Table 1.
Conclusion: Inflammatory markers including hs-CRP and interferon γ are significantly elevated in Eisenmenger syndrome. The causes, consequences and prognostic significance of such elevations need further evaluation.
| Biomarker | Eisenmenger Syndrome n = 22 | Control n = 6 | P Value |
| hs CRP (mg/L) | 3.5 + 2.8 | 0.6 + 0.4 | 0.04 |
| Interferon - γ (pg/ml) | 21.7 + 12.70 | 8.7 + 3.94 | 0.02 |
| Interleukin – 6 (pg/ml) | 12.07 + 19.59 | 2 + 1.22 | 0.22 |
| Interleukin – 2 (pg/ml) | 19.41 + 13.56 | 15 + 12.24 | 0.52 |